Drupal.behaviors.print = function(context) {window.print();window.close();}>
MDx/CDx Focus: Enzo Launches Lung Cancer Dx; Zelboraf Survival Data; Caris' Tumor Profiling Service
November 14, 2012
MDx/CDx Focus: Enzo Launches Lung Cancer Dx; Zelboraf Survival Data; Caris' Tumor Profiling Service
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
ASCO Presentations on PGx Melanoma Drugs Portend Crowded Market for BRAF-Mutated Tumors
June 6, 2012 / Pharmacogenomics Reporter
FDA Approves Two New PGx Drugs, Companion Test for Advanced Melanoma Patients
May 29, 2013 / Pharmacogenomics Reporter
Epic Sciences Developing CTC-based CDx with Drug Firms
August 15, 2012 / GenomeWeb Daily News
PGx Highlights from the American Society of Clinical Oncology's 2012 Meeting
June 14, 2012 / Pharmacogenomics Reporter
Quest Study Finds Sanger-based BRAF Mutation Test More Sensitive than Roche's Cobas Test
June 13, 2012 / Pharmacogenomics Reporter